CN114774392A - Mannase and application thereof - Google Patents
Mannase and application thereof Download PDFInfo
- Publication number
- CN114774392A CN114774392A CN202210378803.5A CN202210378803A CN114774392A CN 114774392 A CN114774392 A CN 114774392A CN 202210378803 A CN202210378803 A CN 202210378803A CN 114774392 A CN114774392 A CN 114774392A
- Authority
- CN
- China
- Prior art keywords
- abl
- dendrobe
- mannase
- ala
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010055059 beta-Mannosidase Proteins 0.000 title claims abstract description 21
- 102100032487 Beta-mannosidase Human genes 0.000 title claims abstract description 18
- 150000004676 glycans Chemical class 0.000 claims abstract description 17
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 17
- 239000005017 polysaccharide Substances 0.000 claims abstract description 17
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 11
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract description 30
- 108090000790 Enzymes Proteins 0.000 abstract description 30
- 238000000034 method Methods 0.000 abstract description 17
- 241000228245 Aspergillus niger Species 0.000 abstract description 16
- 238000006243 chemical reaction Methods 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 14
- 150000003272 mannan oligosaccharides Chemical class 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract 2
- 235000013376 functional food Nutrition 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 32
- 239000013612 plasmid Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 16
- 239000000499 gel Substances 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 239000003550 marker Substances 0.000 description 10
- 238000001962 electrophoresis Methods 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 239000003292 glue Substances 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 239000007853 buffer solution Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 7
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 238000003757 reverse transcription PCR Methods 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 238000012795 verification Methods 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 229930027917 kanamycin Natural products 0.000 description 6
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 6
- 229960000318 kanamycin Drugs 0.000 description 6
- 229930182823 kanamycin A Natural products 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 102000018120 Recombinases Human genes 0.000 description 5
- 108010091086 Recombinases Proteins 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 241001523681 Dendrobium Species 0.000 description 4
- 239000012880 LB liquid culture medium Substances 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000193468 Clostridium perfringens Species 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002581 Glucomannan Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000006167 equilibration buffer Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 108010036413 histidylglycine Proteins 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000001821 nucleic acid purification Methods 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 239000012474 protein marker Substances 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 1
- MCKSLROAGSDNFC-ACZMJKKPSA-N Ala-Asp-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MCKSLROAGSDNFC-ACZMJKKPSA-N 0.000 description 1
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 1
- XUCHENWTTBFODJ-FXQIFTODSA-N Ala-Met-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O XUCHENWTTBFODJ-FXQIFTODSA-N 0.000 description 1
- QKHWNPQNOHEFST-VZFHVOOUSA-N Ala-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C)N)O QKHWNPQNOHEFST-VZFHVOOUSA-N 0.000 description 1
- VNFSAYFQLXPHPY-CIQUZCHMSA-N Ala-Thr-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNFSAYFQLXPHPY-CIQUZCHMSA-N 0.000 description 1
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- NONSEUUPKITYQT-BQBZGAKWSA-N Arg-Asn-Gly Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N)CN=C(N)N NONSEUUPKITYQT-BQBZGAKWSA-N 0.000 description 1
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 1
- NGYHSXDNNOFHNE-AVGNSLFASA-N Arg-Pro-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O NGYHSXDNNOFHNE-AVGNSLFASA-N 0.000 description 1
- JWCCFNZJIRZUCL-AVGNSLFASA-N Arg-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N JWCCFNZJIRZUCL-AVGNSLFASA-N 0.000 description 1
- HUAOKVVEVHACHR-CIUDSAMLSA-N Asn-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N HUAOKVVEVHACHR-CIUDSAMLSA-N 0.000 description 1
- NVWJMQNYLYWVNQ-BYULHYEWSA-N Asn-Ile-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O NVWJMQNYLYWVNQ-BYULHYEWSA-N 0.000 description 1
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 1
- IPPFAOCLQSGHJV-WFBYXXMGSA-N Asn-Trp-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O IPPFAOCLQSGHJV-WFBYXXMGSA-N 0.000 description 1
- GHWWTICYPDKPTE-NGZCFLSTSA-N Asn-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N GHWWTICYPDKPTE-NGZCFLSTSA-N 0.000 description 1
- XBQSLMACWDXWLJ-GHCJXIJMSA-N Asp-Ala-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XBQSLMACWDXWLJ-GHCJXIJMSA-N 0.000 description 1
- SWTQDYFZVOJVLL-KKUMJFAQSA-N Asp-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N)O SWTQDYFZVOJVLL-KKUMJFAQSA-N 0.000 description 1
- TZOZNVLBTAFJRW-UGYAYLCHSA-N Asp-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N TZOZNVLBTAFJRW-UGYAYLCHSA-N 0.000 description 1
- VSMYBNPOHYAXSD-GUBZILKMSA-N Asp-Lys-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O VSMYBNPOHYAXSD-GUBZILKMSA-N 0.000 description 1
- KPSHWSWFPUDEGF-FXQIFTODSA-N Asp-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(O)=O KPSHWSWFPUDEGF-FXQIFTODSA-N 0.000 description 1
- KESWRFKUZRUTAH-FXQIFTODSA-N Asp-Pro-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O KESWRFKUZRUTAH-FXQIFTODSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- WDQXKVCQXRNOSI-GHCJXIJMSA-N Cys-Asp-Ile Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WDQXKVCQXRNOSI-GHCJXIJMSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- INKFLNZBTSNFON-CIUDSAMLSA-N Gln-Ala-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O INKFLNZBTSNFON-CIUDSAMLSA-N 0.000 description 1
- NCWOMXABNYEPLY-NRPADANISA-N Glu-Ala-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O NCWOMXABNYEPLY-NRPADANISA-N 0.000 description 1
- PCBBLFVHTYNQGG-LAEOZQHASA-N Glu-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N PCBBLFVHTYNQGG-LAEOZQHASA-N 0.000 description 1
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 1
- OAGVHWYIBZMWLA-YFKPBYRVSA-N Glu-Gly-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)NCC(O)=O OAGVHWYIBZMWLA-YFKPBYRVSA-N 0.000 description 1
- JZJGEKDPWVJOLD-QEWYBTABSA-N Glu-Phe-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JZJGEKDPWVJOLD-QEWYBTABSA-N 0.000 description 1
- HQTDNEZTGZUWSY-XVKPBYJWSA-N Glu-Val-Gly Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)NCC(O)=O HQTDNEZTGZUWSY-XVKPBYJWSA-N 0.000 description 1
- PUUYVMYCMIWHFE-BQBZGAKWSA-N Gly-Ala-Arg Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PUUYVMYCMIWHFE-BQBZGAKWSA-N 0.000 description 1
- GZUKEVBTYNNUQF-WDSKDSINSA-N Gly-Ala-Gln Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GZUKEVBTYNNUQF-WDSKDSINSA-N 0.000 description 1
- AIJAPFVDBFYNKN-WHFBIAKZSA-N Gly-Asn-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN)C(=O)N AIJAPFVDBFYNKN-WHFBIAKZSA-N 0.000 description 1
- GGEJHJIXRBTJPD-BYPYZUCNSA-N Gly-Asn-Gly Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GGEJHJIXRBTJPD-BYPYZUCNSA-N 0.000 description 1
- LLXVQPKEQQCISF-YUMQZZPRSA-N Gly-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN LLXVQPKEQQCISF-YUMQZZPRSA-N 0.000 description 1
- XLFHCWHXKSFVIB-BQBZGAKWSA-N Gly-Gln-Gln Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O XLFHCWHXKSFVIB-BQBZGAKWSA-N 0.000 description 1
- QITBQGJOXQYMOA-ZETCQYMHSA-N Gly-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QITBQGJOXQYMOA-ZETCQYMHSA-N 0.000 description 1
- GGLIDLCEPDHEJO-BQBZGAKWSA-N Gly-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CN GGLIDLCEPDHEJO-BQBZGAKWSA-N 0.000 description 1
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 1
- MKIAPEZXQDILRR-YUMQZZPRSA-N Gly-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN MKIAPEZXQDILRR-YUMQZZPRSA-N 0.000 description 1
- DCRODRAURLJOFY-XPUUQOCRSA-N His-Ala-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)NCC(O)=O DCRODRAURLJOFY-XPUUQOCRSA-N 0.000 description 1
- OSZUPUINVNPCOE-SDDRHHMPSA-N His-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O OSZUPUINVNPCOE-SDDRHHMPSA-N 0.000 description 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 1
- QADCTXFNLZBZAB-GHCJXIJMSA-N Ile-Asn-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N QADCTXFNLZBZAB-GHCJXIJMSA-N 0.000 description 1
- QSPLUJGYOPZINY-ZPFDUUQYSA-N Ile-Asp-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QSPLUJGYOPZINY-ZPFDUUQYSA-N 0.000 description 1
- IOVUXUSIGXCREV-DKIMLUQUSA-N Ile-Leu-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IOVUXUSIGXCREV-DKIMLUQUSA-N 0.000 description 1
- NZGTYCMLUGYMCV-XUXIUFHCSA-N Ile-Lys-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N NZGTYCMLUGYMCV-XUXIUFHCSA-N 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- PJYSOYLLTJKZHC-GUBZILKMSA-N Leu-Asp-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(N)=O PJYSOYLLTJKZHC-GUBZILKMSA-N 0.000 description 1
- CLVUXCBGKUECIT-HJGDQZAQSA-N Leu-Asp-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CLVUXCBGKUECIT-HJGDQZAQSA-N 0.000 description 1
- CIVKXGPFXDIQBV-WDCWCFNPSA-N Leu-Gln-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CIVKXGPFXDIQBV-WDCWCFNPSA-N 0.000 description 1
- KUEVMUXNILMJTK-JYJNAYRXSA-N Leu-Gln-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KUEVMUXNILMJTK-JYJNAYRXSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 1
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- YFGWNAROEYWGNL-GUBZILKMSA-N Lys-Gln-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O YFGWNAROEYWGNL-GUBZILKMSA-N 0.000 description 1
- PBLLTSKBTAHDNA-KBPBESRZSA-N Lys-Gly-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PBLLTSKBTAHDNA-KBPBESRZSA-N 0.000 description 1
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 1
- PFZWARWVRNTPBR-IHPCNDPISA-N Lys-Leu-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCCCN)N PFZWARWVRNTPBR-IHPCNDPISA-N 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- JIYJYFIXQTYDNF-YDHLFZDLSA-N Phe-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N JIYJYFIXQTYDNF-YDHLFZDLSA-N 0.000 description 1
- METZZBCMDXHFMK-BZSNNMDCSA-N Phe-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N METZZBCMDXHFMK-BZSNNMDCSA-N 0.000 description 1
- MJOJSHOTYWABPR-WIRXVTQYSA-N Phe-Trp-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 MJOJSHOTYWABPR-WIRXVTQYSA-N 0.000 description 1
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 1
- INXAPZFIOVGHSV-CIUDSAMLSA-N Pro-Asn-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1 INXAPZFIOVGHSV-CIUDSAMLSA-N 0.000 description 1
- FKVNLUZHSFCNGY-RVMXOQNASA-N Pro-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 FKVNLUZHSFCNGY-RVMXOQNASA-N 0.000 description 1
- SWRNSCMUXRLHCR-ULQDDVLXSA-N Pro-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 SWRNSCMUXRLHCR-ULQDDVLXSA-N 0.000 description 1
- MDAWMJUZHBQTBO-XGEHTFHBSA-N Pro-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H]1CCCN1)O MDAWMJUZHBQTBO-XGEHTFHBSA-N 0.000 description 1
- DIDLUFMLRUJLFB-FKBYEOEOSA-N Pro-Trp-Tyr Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC4=CC=C(C=C4)O)C(=O)O DIDLUFMLRUJLFB-FKBYEOEOSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- BCKYYTVFBXHPOG-ACZMJKKPSA-N Ser-Asn-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N BCKYYTVFBXHPOG-ACZMJKKPSA-N 0.000 description 1
- FYUIFUJFNCLUIX-XVYDVKMFSA-N Ser-His-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O FYUIFUJFNCLUIX-XVYDVKMFSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- AXKJPUBALUNJEO-UBHSHLNASA-N Ser-Trp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O AXKJPUBALUNJEO-UBHSHLNASA-N 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- JVTHIXKSVYEWNI-JRQIVUDYSA-N Thr-Asn-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JVTHIXKSVYEWNI-JRQIVUDYSA-N 0.000 description 1
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 1
- YOPQYBJJNSIQGZ-JNPHEJMOSA-N Thr-Tyr-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 YOPQYBJJNSIQGZ-JNPHEJMOSA-N 0.000 description 1
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- RQKMZXSRILVOQZ-GMVOTWDCSA-N Trp-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N RQKMZXSRILVOQZ-GMVOTWDCSA-N 0.000 description 1
- ICPRIGUXAFULPH-ILWGZMRPSA-N Trp-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)N)C(=O)O ICPRIGUXAFULPH-ILWGZMRPSA-N 0.000 description 1
- CYLQUSBOSWCHTO-BPUTZDHNSA-N Trp-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N CYLQUSBOSWCHTO-BPUTZDHNSA-N 0.000 description 1
- CDHQEOXPWBDFPL-QWRGUYRKSA-N Tyr-Gly-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDHQEOXPWBDFPL-QWRGUYRKSA-N 0.000 description 1
- AXWBYOVVDRBOGU-SIUGBPQLSA-N Tyr-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N AXWBYOVVDRBOGU-SIUGBPQLSA-N 0.000 description 1
- QARCDOCCDOLJSF-HJPIBITLSA-N Tyr-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QARCDOCCDOLJSF-HJPIBITLSA-N 0.000 description 1
- ZOBLBMGJKVJVEV-BZSNNMDCSA-N Tyr-Lys-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O ZOBLBMGJKVJVEV-BZSNNMDCSA-N 0.000 description 1
- LVFZXRQQQDTBQH-IRIUXVKKSA-N Tyr-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LVFZXRQQQDTBQH-IRIUXVKKSA-N 0.000 description 1
- YOTRXXBHTZHKLU-BVSLBCMMSA-N Tyr-Trp-Met Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(O)=O)C1=CC=C(O)C=C1 YOTRXXBHTZHKLU-BVSLBCMMSA-N 0.000 description 1
- REJBPZVUHYNMEN-LSJOCFKGSA-N Val-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N REJBPZVUHYNMEN-LSJOCFKGSA-N 0.000 description 1
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 1
- ZLFHAAGHGQBQQN-AEJSXWLSSA-N Val-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZLFHAAGHGQBQQN-AEJSXWLSSA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- ZXAGTABZUOMUDO-GVXVVHGQSA-N Val-Glu-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZXAGTABZUOMUDO-GVXVVHGQSA-N 0.000 description 1
- WNZSAUMKZQXHNC-UKJIMTQDSA-N Val-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N WNZSAUMKZQXHNC-UKJIMTQDSA-N 0.000 description 1
- POFQRHFHYPSCOI-FHWLQOOXSA-N Val-Trp-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O)N POFQRHFHYPSCOI-FHWLQOOXSA-N 0.000 description 1
- SVLAAUGFIHSJPK-JYJNAYRXSA-N Val-Trp-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CO)C(=O)O)N SVLAAUGFIHSJPK-JYJNAYRXSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- HDFXRQJQZBPDLF-UHFFFAOYSA-L disodium hydrogen carbonate Chemical compound [Na+].[Na+].OC([O-])=O.OC([O-])=O HDFXRQJQZBPDLF-UHFFFAOYSA-L 0.000 description 1
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- -1 glucomannan oligosaccharide Chemical class 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 229940025902 konjac mannan Drugs 0.000 description 1
- 108010047926 leucyl-lysyl-tyrosine Proteins 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 230000007108 local immune response Effects 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000008621 organismal health Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 108010018625 phenylalanylarginine Proteins 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 150000003214 pyranose derivatives Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- LEAHFJQFYSDGGP-UHFFFAOYSA-K trisodium;dihydrogen phosphate;hydrogen phosphate Chemical compound [Na+].[Na+].[Na+].OP(O)([O-])=O.OP([O-])([O-])=O LEAHFJQFYSDGGP-UHFFFAOYSA-K 0.000 description 1
- 108010038745 tryptophylglycine Proteins 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/2488—Mannanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses mannase ABL-03475, an amino acid sequence of which is shown in SEQ ID NO. 1, and the mannase ABL-03475 is applied to preparation of dendrobe oligosaccharide by utilizing dendrobe polysaccharide, wherein dendrobe polysaccharide with rich sources is taken as a raw material, specific mannase ABL-03475 screened from Aspergillus niger is used, and mannan oligosaccharide with wider activity can be prepared by a biological enzyme conversion method, so that a technical method is provided for further utilizing dendrobe, and a new preparation method is provided for preparing a functional mannan oligosaccharide raw material in a functional food industry.
Description
Technical Field
The invention relates to mannase ABL-03475 and application thereof in preparation of dendrobe oligosaccharide by utilizing dendrobe polysaccharide.
Background
Mannooligosaccharides (MOS), commonly known as manna-oligosaccharides, are used as oligosaccharides. The small molecular saccharide is formed by connecting several mannose or mannose and glucose through beta-1, 4, beta-1, 6, alpha-1, 2, alpha-1, 6 and other glycosidic bonds. MOS from different sources have different structures, for example, the studied konjac mannan oligosaccharide consists of glucose and mannose with a molecular ratio of 1:1.5, a main chain is connected through beta-1, 4 glycosidic bonds, and a side chain is connected through beta-1, 3 glycosidic bonds. The main chain of the glucomannan oligosaccharide derived from the yeast cell wall is formed by connecting pyranose residues through alpha-1, 6 glycosidic bonds, and the glycosidic bonds of the side chains are alpha-1, 2 and alpha-1, 3.
Besides the functions of oxidation resistance, lipid metabolism regulation and the like, the main physiological function of MOS is to regulate the generation and community structure of intestinal probiotics, so as to inhibit intestinal pathogenic bacteria, improve the immunity of the organism and maintain the health of the organism. Bifidobacteria are the most important dominant flora for maintaining intestinal health, and a large number of experiments show that the intake of MOS can promote the proliferation and the function of the bifidobacteria so as to inhibit the growth and the propagation of harmful bacteria such as clostridium perfringens (clostridium perfringens). MOS can also improve the diversity of intestinal microorganisms, promote the proliferation of intestinal probiotics and further maintain the health of the intestinal tract. The harmful bacteria invasion test shows that MOS can reduce the gene expression of intestinal mucosa cell factors TLR4 and IL-1 beta, and increase the number of immune cells such as intestinal epithelial intercellular lymphocytes and goblet cells, thereby improving the local immune response of the organism and further maintaining the intestinal health.
At present, the main methods for obtaining MOS in laboratories and production are as follows: extraction from natural products, acid hydrolysis or enzymatic hydrolysis of mannans. Mannan is mainly present in cell walls of various microorganisms and plants such as konjac glucomannan and locust bean gum in nature. Due to no charge, complex components and the like, the process of separating and purifying MOS from a natural product is complex, the operation is difficult, and the loss of the product is large; when the MOS is prepared by the acid hydrolysis method, the side reactions are more, so that the product components are complex, the pure product is difficult to obtain, and the yield is low; because the catalytic enzyme has the characteristics of specificity, high efficiency and the like, the MOS prepared by the enzyme method is the most common means with relative safety, high efficiency and simple operation.
Disclosure of Invention
The invention provides mannanase ABL-03475, which is derived from Aspergillus niger (Aspergillus niger), and the nucleic acid sequence of the mannanase is shown as SEQ ID NO:1, and the amino acid sequence is shown as SEQ ID NO: 2, respectively.
The invention also aims to apply the mannase ABL-03475 in preparation of dendrobium oligosaccharide.
According to the invention, a mannase gene ABL-03475 is successfully cloned from Aspergillus niger, the mannase gene ABL-03475 is cloned on a pColdTF vector, and is introduced into BL21 for heterologous expression, the mannase ABL-03475 is successfully obtained in vitro, and the purified mannase ABL-03475 reacts with dendrobe polysaccharide to convert dendrobe polysaccharide into dendrobe oligosaccharide.
The mannase ABL-03475 has the optimum temperature of 35 ℃, the optimum pH of 7.5 and the highest enzyme activity of 68U/mL; the mannase ABL-03475 can hydrolyze dendrobium polysaccharide into mannan oligosaccharide.
The invention has the advantages and technical effects that:
the mannase ABL-03475 provided by the invention has high catalytic efficiency and strong specificity. The dendrobe polysaccharide can be almost completely converted into dendrobe oligosaccharide after reaction for 30min under the condition of neutral pH at 30-40 ℃, and the whole reaction operation process is simple, short in reaction time and low in pollution, so that the method is a mild, environment-friendly and efficient dendrobe oligosaccharide production technology and is suitable for industrial production.
Drawings
FIG. 1 is an agarose electrophoresis picture of Aspergillus niger total RNA, wherein M: BM5000 DNA Marker; lanes 1, 2: aspergillus niger RNA;
FIG. 2 is an agarose electrophoresis picture of the target gene abl-03475, wherein M: DL2000 DNA Marker; lane 1: gene abl-03475;
FIG. 3 is a clone validation agarose electrophoresis of the target gene abl-03475, wherein M: DL2000 DNA Marker; lanes 1-3: verifying the gene abl-03475 by PCR;
FIG. 4 shows the recovery of the target gene gel and the extraction of pCold TF plasmid, wherein (a) M: DL2000 DNA Marker; lane 1: recovering abl-03475 gene PCR amplification glue; (b) m: DL5000DNA Marker; lanes 1-2: extracting pCold TF (5769bp) plasmid;
FIG. 5 shows the recovery of the target gene and pCold TF plasmid after double enzyme gel cutting, wherein (a) M: DL5000DNA Marker; lane 1: recovering abl-034751(1,008bp) gene double-enzyme gel cutting; (b) m: DL5000DNA Marker; lane 1: recovering pColdTF vector + Kpn I and Xba I by double-enzyme gel cutting;
fig. 6 is the result of PCR verification of recombinant plasmid, wherein M: DL2000 DNA Marker; lanes 1-4: PCR verification of the pColdTF-abl-03475 recombinant plasmid;
FIG. 7 shows the SDS-PAGE analysis of the recombinant protein, wherein M: protein Marker; lane 1: pColdTF-ABL-03475 recombinant protein;
FIG. 8 shows the SDS-PAGE analysis of the purified recombinant protein, M: a protein Marker; lanes 1-3: pColdTF-ABL-03475 crude protein; lane 4: pCold TF-ABL-03475 is loaded on a column and then collected by using 10mM imidazole washing liquid; lane 5: purified ABL-03475 protein;
FIG. 9 shows the relative enzyme activities of heterologous expression recombinase ABL-03475 at different pH values;
FIG. 10 shows the relative enzyme activities of heterologous expression recombinase ABL-03475 at different temperatures;
FIG. 11 shows the TLC method for detecting the product of the hydrolysis of dendrobii polysaccharide by recombinant protease during purification: 1: a dendrobe polysaccharide reference substance; 2: reacting the crude enzyme solution with a substrate before purification; 3: a dendrobe polysaccharide reference substance; 4: the pure enzyme solution reacts with the substrate.
Detailed Description
The present invention is further described in detail with reference to the following drawings and examples, but the scope of the present invention is not limited to the above description, and reagents and methods used in the examples, unless otherwise specified, are conventional reagents and conventional methods;
in the examples pCold TF: expression vectors, available from baozhi bioengineering (Dalian); coli Trans 1-T1: cloning hosts, purchased from Beijing Quanji Biotech, Inc.; coli BL21(DE 3): expression hosts, purchased from Beijing Quanjin Biotechnology Ltd;
LB medium: adding yeast extract of 5g/L, peptone of 10g/L and NaCl of 10g/L into deionized water of 800mL, stirring thoroughly to dissolve, diluting to 1000mL, sterilizing at 121 ℃ for 20min, and storing at room temperature for later use; the concentration of kanamycin added to the LB kanamycin-resistant medium is 50 mug/mL; if the solid LB culture medium is prepared, 20g/L agar is added for screening positive clones.
Antibiotics: kanamycin (Kanamycin) stock (50 mg/mL).
Other reagents: t is a unit of4DNA ligase, Fastpfu DNA polymerase, was purchased from Beijing Quanjin Biotechnology Ltd. BM5000, DL2000, high purity plasmid extraction kit and nucleic acid purification kit were purchased from Beijing Baitake biotechnology, Inc., and RNA extraction kit Fungal RNAKit (OMEGA) was purchased from Kunming mercy-Summit technology, Inc. Restriction enzymes: kpn I and Xba I were purchased from Beijing Quanji gold Biotechnology Ltd.
Example 1: cloning, recombinant plasmid construction and transformation of mannanase ABL-03475
1. Aspergillus niger total RNA extraction
Washing spores of Aspergillus niger NG1306 with sterile water to obtain spore suspension, inoculating into 150mL triangular flask containing 50mL liquid culture medium, shake culturing at 30 deg.C and 180r/min for 4d, extracting total RNA according to OMEGA kit instruction (RNA is easily degradable and is not suitable for overnight storage), and obtaining the result shown in FIG. 1; a band consistent with the expected fragment size is visible in the figure, indicating that Aspergillus niger RNA was successfully extracted and can be used as a template for RT-PCR amplification.
2. Amplification of mannanase gene
The extracted Aspergillus niger total RNA is subjected to RT-PCR by adopting a method and steps of a reverse transcription Kit PrimeScriptTM One Step RT-PCR Kit Ver.2; RT-PCR amplification conditions (one-step method): 50 ℃, 30min, pre-denaturation 94 ℃,2 min; denaturation at 94 ℃ for 30 s; annealing at 56 ℃ for 30 s; extension at 72 ℃, 90s, 35 cycles; re-extension at 72 ℃ for 10min, and RT-PCR system as shown in Table 1:
TABLE 1 RT-PCR System
3.PCR product purification
The procedures of the agarose gel DNA recovery kit purchased from Baitach corporation in laboratory are referred to the instruction for operation and electrophoresis detection, the Aspergillus niger total RNA is amplified by RT-PCR, the product gel is recovered, 5 microlitre of gel recovery product is taken for agarose gel electrophoresis detection (Marker is DL5000), and the result is shown in figure 2. As can be seen from the figure, the target gene abl-03475(1008bp) is successfully amplified.
4. Subcloning and sequencing of genes of interest
(1) Connecting: mixing 4 μ L of the target fragment with 1 μ L of pEASY-T1 Simple vector, and connecting at 37 deg.C for 20 min;
(2) and (3) transformation: taking out E.coli Trans1-T1 competent cells stored at-80 ℃, putting the competent cells on ice, adding the ligation product, uniformly mixing, and carrying out ice bath for 20-30 min; heat shock is carried out for 90s at 42 ℃, ice bath is carried out for 3min, and then 1mL of LB liquid culture medium is added; incubating in a shaking table at 37 ℃ for 1h, centrifuging at 5000rpm for 5min, discarding the supernatant, adding 200 μ L sterile water, mixing, uniformly coating on LB culture medium containing kanamycin with final concentration of 100 μ g/mL, and inversely placing in an incubator at 37 ℃ for culturing for 14-16 h;
(3) extracting plasmids according to the steps of the Baitach plasmid extraction kit, and performing PCR verification by taking the plasmids as a template;
(4) sequencing: the PCR is verified to be positive and sent to be sequenced, and the sequencing result is compared with the template sequence;
subcloning a target gene in a pEASY-T1 Simple Cloning vector, transforming Escherichia coli E.coli DH5 alpha, selecting a grown positive clone, culturing at 37 ℃ and 180rpm for 8-12h, extracting a plasmid, and then extracting a specific primer PCR amplification verification result as shown in figure 3, wherein the positive clone respectively selects transformants to Kunming Shuoqing biology Limited for sequencing, and a sequencing primer is an M13 universal primer; as can be seen from the figure, the transformants picked up by abl-03475 all amplified bands consistent with the size of the target fragment, which indicates that all transformants were positive, and the target gene was successfully transferred into the cloning host.
5. Design of target gene primer
Comprehensively analyzing enzyme cutting sites contained in related genes, primer annealing temperature and other factors, designing primers, designing front and rear primers respectively containing Kpn I and Xba I enzyme cutting site base sequences, and entrusting Kunming Optimoku Biotechnology Limited to synthesize the primers;
TABLE 2 abl-03475 primers with cleavage site
Note: underlined in the tables indicate the restriction sites
After obtaining the target gene abl-03475 by PCR, double digestion was performed with Kpn I and Xba I, and the pCold TF vector was double digested with the same enzymes, followed by cloning the target gene into the pCold TF vector using T4 ligase.
6. Target gene amplification and extraction of expression plasmid pCold TF
The subclone-positive strain and the strain containing pCold TF vector were inoculated into LB medium containing kanamycin and ampicillin at final concentrations of 50. mu.g/mL and 50. mu.g/mL, respectively, cultured at 37 ℃ and 180rpm for 12 hours, and then plasmids were extracted using the kit. The high fidelity Fastpfu DNA polymerase is adopted to amplify the target gene, and the amplification system is shown in Table 3.PCR amplification conditions: pre-denaturation at 95 deg.C for 2 min; denaturation at 95 ℃ for 20 s; annealing at 56 deg.C for 20 s; extension 72 ℃, 90s, 35 cycles, and finally extension for 10min at 72 ℃. Purifying the PCR product by using a nucleic acid purification kit (Beijing Baitaike biotechnology, Inc.); the PCR conditions are shown in Table 3:
TABLE 3 PCR reaction conditions
PCR amplification (a primer with a restriction enzyme site) and pColdTF empty plasmid extraction products are carried out by taking a plasmid which is successfully subcloned as a template, and agarose gel electrophoresis detection (DL 5000 is Marker) is carried out on a 5 mu L gel recovery product, and the result is shown in figure 4.
7. Digestion and ligation of plasmid
The enzyme digestion reaction system is shown in Table 4, and the ligation reaction system is shown in Table 5; respectively carrying out overnight enzyme digestion gel recovery on the target gene and the plasmid by using corresponding restriction enzymes; detecting the recovered product of the identification gel by using 1.2% agarose gel electrophoresis, connecting for about 16h as shown in figure 5, and then carrying out transformation;
TABLE 4 double digestion reaction system for abl-03475 and pCold TF vectors
TABLE 5 DNA fragment ligation System
8. Preparation of competent cells of Escherichia coli BL21
(1) Taking out the preserved strain from a refrigerator at minus 80 ℃, diluting and coating or marking an LB solid flat plate, and inversely placing the flat plate in an incubator at 37 ℃ for culturing for 16-24 h;
(2) selecting a single colony, inoculating the single colony in 15mL LB liquid culture medium, and culturing at 37 ℃ and 200rpm for 12-16 h;
(3) inoculating the culture solution at 1% ratio into 100mL LB liquid culture medium, 37 deg.CCulturing at 200rpm for 2-3h to OD6000.4-0.6, ice-bath for 10 min;
(4) the ice-cooled culture solution was dispensed into two 50mL centrifuge tubes, centrifuged at 5000rpm for 5min at 4 deg.C, the supernatant was discarded, and 30mL of pre-cooled 0.1M CaCl was added to each tube2The solution was gently resuspended, centrifuged at 5000rpm at 4 ℃ for 5min, and the supernatant was discarded.
(5) 30mL of precooled 0.1M CaCl was added to each tube2After the solution is gently resuspended, the solution is iced for 30min and centrifuged for 5min at 5000rpm and 4 ℃;
(6) the supernatant was aspirated off, and 2mL of pre-cooled 15% glycerol plus 0.1M CaCl were added to each tube2The solution was gently resuspended and dispensed into sterile 1.5mL centrifuge tubes at 100. mu.L/tube and stored at-80 ℃.
9. Transformation of competent cells of E.coli
(1) Taking out Escherichia coli competence from refrigerator at-80 deg.C, thawing on ice, adding 5 μ L ligation product into 50 μ L competent cell, gently mixing, standing in ice bath for 30min, and performing the process under strict aseptic condition;
(2) floating the centrifuge tube in a water bath at 42 ℃ for 30s to perform heat shock, standing on ice for incubation for 2min, and avoiding shaking in the moving process;
(3) adding 0.5mL of sterilized LB culture medium into a centrifuge tube, and recovering and culturing for 1-2h in a shaking table at the temperature of 37 ℃ and the rpm of 200;
(4) the cells were collected by centrifugation at 4000rpm for 5min, the supernatant was discarded, 100. mu.L of sterile water was added to resuspend the cells, the cells were spread on LB plates containing ampicillin resistance at a final concentration of 50. mu.g/mL by aseptic technique, and the cells were cultured in an inverted incubator at 37 ℃.
10. Coli DH5 alpha transformed with recombinant plasmid and verified
Carrying out plasmid enzyme digestion verification according to the operation of the kit, carrying out nucleic acid sequence sequencing verification after the verification is correct, wherein the sequencing primer uses universal primers pCold TF-F (5'-CCACTTTCAACGAGCTGATG-3') and pCold TF-R (5'-GGCAGGGATCTTAGATTCTG-3') of pCold TF; transformants of abl-03475 were picked and cultured overnight at 37 ℃ and the quality-improved pellets were verified by PCR using universal primers, the PCR results are shown in FIG. 6.
11. Transformation of recombinant plasmid into E.coli BL21(DE3)
And transferring the positive recombinants which are verified to be correct into E.coli BL21(DE3) for induced expression, and storing the strain at-80 ℃.
12. Prokaryotic expression and enzyme activity analysis of target protein
And (3) inducing expression of the target protein: the constructed recombinant strain is inoculated in 15mL LB liquid culture medium containing 50 mug/mL of ampicillin with final concentration, and cultured for 12h at 37 ℃ and 180 rpm; then inoculating at a ratio of 1%, culturing at 37 deg.C and 180rpm for 2-3 hr until OD600At 0.6, IPTG was added to a final concentration of 0.5mmol/L, and the mixture was induced at 180rpm and 15 ℃ for 24 hours. After the induction, the cells were centrifuged at 5000rpm for 5min at 4 ℃ and then harvested with ddH2And O, washing the thalli twice, then re-suspending with 10mL PBS, carrying out cell disruption by adopting a nano homogenizer, detecting the protein expression condition by using 10% SDS-PAGE electrophoresis, and detecting the enzyme activity by using dendrobe polysaccharide as a substrate.
13. SDS-PAGE analysis
5% of the concentrated gum and 10% of the separating gum were prepared, the formulation being shown in Table 7:
TABLE 7 formulation of Polyacrylamide gels
Manufacturing a gel plate:
firstly, cleaning and drying a glass rubber plate for assembly, then preparing separation glue according to the upper table system, fully and uniformly mixing the separation glue, quickly filling the separation glue between the glass rubber plates to a scale mark, adding absolute ethyl alcohol, completely removing the absolute ethyl alcohol on the separation glue after gel is completely polymerized, adding concentrated glue prepared according to the upper table system, and inserting a comb between the glass plates;
② sample treatment
Adding SDS-PAGE Loading Buffer into the sample according to the proportion of 10%, fully and uniformly mixing, and boiling for 5 min;
(iii) sampling
Adding 20 mu L of the treated sample into a sample loading groove, and simultaneously taking 5 mu L of protein standard substance as a control;
(iv) electrophoresis
Connecting a power supply to carry out electrophoresis, wherein the gel concentration current is 20mA and is about 30min, the gel separation current is 60mA and is about 90min, and the electrophoresis is carried out until bromophenol blue moves to the lower end of an electrophoresis tank;
dyeing
Taking the glue out of the glass plate, adding a proper amount of Coomassie brilliant blue staining solution, and slightly oscillating and staining for 30min at 37 ℃;
sixth of color removal
Taking out the glue, recovering the dyeing liquid, putting the glue in the decoloring liquid, and decoloring for many times at 50 ℃ until the protein band is clear.
SDS-PAGE analysis shows that the expression protein (the molecular weight of the target protein is 37kDa and the carrier tag protein is 52kDa to 89kDa) of BL21/pCold TF-ABL-03475 recombinant plasmid detects that the target band is 89kDa, and as shown in figure 7, recombinase ABL-03475 is obviously expressed.
14. Recombinant protein purification
His-Tag in this experiment was bound to the C-terminus of the target protein. His-Tag can be combined with Ca2+、Mg2+、Ni2+、Cu2+,Fe3+And the like, so that the separation and purification of the target protein are realized. The experiment adopts a nickel column of a polyhistidine tag (9His-tag), and the specific steps of protein purification are as follows:
1) column assembling: according to the amount of protein to be purified, a proper amount of resuspended medium is filled into the chromatographic column, and the chromatographic column is kept still for precipitation.
2) Balancing: the column is equilibrated with 5-10 column volumes of equilibration buffer. For His label recombinant protein with strong binding capacity, the balance buffer solution is properly added with 10-20mM low-concentration imidazole, so that the specific binding can be improved.
3) Sampling: the sample is centrifuged or filtered using a 0.45 μm filter to prevent clogging of the column. And selecting an ultrafiltration tube with proper size for buffer solution replacement, so that the sample buffer solution is as consistent as possible with the balance buffer solution, and the binding efficiency of the target protein His tag is improved.
4) Washing: after the sample loading is finished, washing with 5-10 times of column volume of equilibrium liquid, and collecting effluent liquid.
5) And (3) elution: and (3) carrying out gradient elution on the target protein by using imidazole with different concentrations, and collecting effluent to carry out SDS-PAGE analysis.
Equilibration buffer: 300mM NaCl, 50mM NaH2PO4、10mM Mimidazole、10mM Tris base,pH=8.0。
The purification results are shown in FIG. 8, and recombinase ABL-03475 was successfully purified.
15. Recombinase ABL-03475 property study
15.1 relative enzyme Activity under different pH conditions
Buffers at different pH values: 50mM disodium hydrogenphosphate-citric acid buffer (pH 2.0-6.0), 50mM disodium hydrogenphosphate-sodium dihydrogenphosphate buffer (pH 7.0-8.0), and 50mM sodium carbonate-sodium bicarbonate buffer (pH 8.5-10).
Adding 5 μ L pure enzyme and 5g/L substrate dissolved in different buffer solutions into 100 μ L reaction system, performing enzymolysis reaction at 37 deg.C for 30min, adding 100 μ L DNS to terminate the reaction, boiling for 7min, and detecting absorbance at 563 nm. The pH optimum activity was defined as 100%. Mixing 5 μ L pure enzyme with buffer solution of pH 4-9, standing at 4 deg.C for 24h, reacting at 30 deg.C for 30min to detect enzyme residual activity, and determining enzyme stability in buffer solution of different pH.
The results are shown in FIG. 9, and the optimum pH is obtained by detecting the enzyme activity of the recombinant protein in a buffer solution with pH 2-10 and reacting at 35 ℃ for 30 min. The results showed that the enzyme had an optimum pH of 7.5 and was relatively stable in a buffer of pH 6-9, confirming that the enzyme is suitable for a more neutral environment.
15.2 relative enzyme Activity at different temperatures
Adding 5 μ L pure enzyme and 5g/L substrate into 100mL reaction system, performing enzymolysis reaction in buffer solution with optimum pH at 10-60 deg.C for 30min, adding 100mL DNS to stop reaction, boiling for 7min, and detecting light absorption value at 540 nm. The activity at the optimum temperature was defined as 100%.
The result is shown in figure 10, and the optimum temperature is obtained by detecting the enzyme activity of the recombinant protein at 10-60 ℃ for 30min under the optimum pH condition by using the dendrobium polysaccharide as a substrate. The results showed that the optimum temperature of the enzyme was 35 ℃.
15.3 analysis of recombinant proteolysis of Dendrobium polysaccharide products
The method comprises the steps of centrifuging the cells subjected to ultrasonic disruption to obtain a crude enzyme solution, reacting the crude enzyme solution with a substrate of 5g/L of dendrobe polysaccharide, wherein the reaction system is 100 mu L of the crude enzyme solution and 400 mu L of the substrate, reacting for 30min at 35 ℃, and detecting a hydrolysis product by TLC (thin layer chromatography), and the result is shown in figure 11, wherein the ABL-03475 is the same as a product obtained by hydrolyzing dendrobe polysaccharide with the crude enzyme solution obtained by solid fermentation of Aspergillus niger, and the dendrobe polysaccharide can be hydrolyzed into dendrobe oligosaccharide in a short time.
Sequence listing
<110> Kunming academy of academic
<120> mannase and application thereof
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1008
<212> DNA
<213> Aspergillus niger (Aspergillus niger)
<400> 1
atgttcgcca aattgtccct tctttcgctt cttttcagct ctgctgcgct gggcgcctcc 60
aaccagactc tgtcctatgg caacattgac aagtctgcca cccccggcgc cagagcgctc 120
ctgaagtaca tccagcttca gtatggatcg cactacatat ctggacagca ggacatcgac 180
agctggaact gggtcgagaa gaacattggt gtggcccctg ccatcctcgg cagcgacttc 240
acctactact cgccatcggc tgttgcccac ggcggcaagt ctcacgcggt cgaggatgta 300
atccagcacg ccggtcgcaa tggaatcaat gccctggttt ggcattggta cgctcccacc 360
tgtctgctcg ataccgataa agagccgtgg tacaagggat tctacaccga ggccacctgc 420
ttcaacgtgt ctgaagccgt caacgaccat ggcaacggca ccaactacaa gctcctgctg 480
cgtgatatcg acgccattgc tgctcagatc aagcgcctgg atcaggccaa cgtgcccatt 540
ctcttccgcc cgctccacga gcccgagggt ggctggttct ggtggggtgc ccagggtcct 600
gctcccttca agaagctgtg ggatattctc tacgaccgca tcactcgcta ccacaacctc 660
cacaacttgg tctgggtttg caacactgct gatccggcct ggtatcccgg aaacgacaaa 720
tgcgacatcg ccaccatcga tcactatccc gccgttggtg accacggagt cgcggccgac 780
cagtacaaga aactccagac cctgaccaag aacgagaggg ttttggctat ggcagaagtt 840
ggccccattc cggaccccga tatgcaggct cgtgagaatg tcaactgggc ttactggatg 900
gtttggtccg gtgagttcat tgaggatggt aagcagaacc ctaaccagtt cttgcacaag 960
gtgtacaacg acacccgggt tgtggctctg aactgggaag gggcttaa 1008
<210> 2
<211> 335
<212> PRT
<213> Aspergillus niger (Aspergillus niger)
<400> 2
Met Phe Ala Lys Leu Ser Leu Leu Ser Leu Leu Phe Ser Ser Ala Ala
1 5 10 15
Leu Gly Ala Ser Asn Gln Thr Leu Ser Tyr Gly Asn Ile Asp Lys Ser
20 25 30
Ala Thr Pro Gly Ala Arg Ala Leu Leu Lys Tyr Ile Gln Leu Gln Tyr
35 40 45
Gly Ser His Tyr Ile Ser Gly Gln Gln Asp Ile Asp Ser Trp Asn Trp
50 55 60
Val Glu Lys Asn Ile Gly Val Ala Pro Ala Ile Leu Gly Ser Asp Phe
65 70 75 80
Thr Tyr Tyr Ser Pro Ser Ala Val Ala His Gly Gly Lys Ser His Ala
85 90 95
Val Glu Asp Val Ile Gln His Ala Gly Arg Asn Gly Ile Asn Ala Leu
100 105 110
Val Trp His Trp Tyr Ala Pro Thr Cys Leu Leu Asp Thr Asp Lys Glu
115 120 125
Pro Trp Tyr Lys Gly Phe Tyr Thr Glu Ala Thr Cys Phe Asn Val Ser
130 135 140
Glu Ala Val Asn Asp His Gly Asn Gly Thr Asn Tyr Lys Leu Leu Leu
145 150 155 160
Arg Asp Ile Asp Ala Ile Ala Ala Gln Ile Lys Arg Leu Asp Gln Ala
165 170 175
Asn Val Pro Ile Leu Phe Arg Pro Leu His Glu Pro Glu Gly Gly Trp
180 185 190
Phe Trp Trp Gly Ala Gln Gly Pro Ala Pro Phe Lys Lys Leu Trp Asp
195 200 205
Ile Leu Tyr Asp Arg Ile Thr Arg Tyr His Asn Leu His Asn Leu Val
210 215 220
Trp Val Cys Asn Thr Ala Asp Pro Ala Trp Tyr Pro Gly Asn Asp Lys
225 230 235 240
Cys Asp Ile Ala Thr Ile Asp His Tyr Pro Ala Val Gly Asp His Gly
245 250 255
Val Ala Ala Asp Gln Tyr Lys Lys Leu Gln Thr Leu Thr Lys Asn Glu
260 265 270
Arg Val Leu Ala Met Ala Glu Val Gly Pro Ile Pro Asp Pro Asp Met
275 280 285
Gln Ala Arg Glu Asn Val Asn Trp Ala Tyr Trp Met Val Trp Ser Gly
290 295 300
Glu Phe Ile Glu Asp Gly Lys Gln Asn Pro Asn Gln Phe Leu His Lys
305 310 315 320
Val Tyr Asn Asp Thr Arg Val Val Ala Leu Asn Trp Glu Gly Ala
325 330 335
<210> 3
<211> 30
<212> DNA
<213> Artificial sequence (Artificial)
<400> 3
ggggtaccat gttcgccaaa ttgtcccttc 30
<210> 4
<211> 29
<212> DNA
<213> Artificial sequence (Artificial)
<400> 4
gctctagatt aagccccttc ccagttcag 29
Claims (2)
1. The mannase ABL-03475 has an amino acid sequence shown in SEQ ID NO. 1.
2. The use of the mannanase ABL-03475 of claim 1 in the preparation of dendrobe oligosaccharide from dendrobe polysaccharide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210378803.5A CN114774392A (en) | 2022-04-12 | 2022-04-12 | Mannase and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210378803.5A CN114774392A (en) | 2022-04-12 | 2022-04-12 | Mannase and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114774392A true CN114774392A (en) | 2022-07-22 |
Family
ID=82428914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210378803.5A Pending CN114774392A (en) | 2022-04-12 | 2022-04-12 | Mannase and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114774392A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024056643A1 (en) * | 2022-09-15 | 2024-03-21 | Novozymes A/S | Fungal signal peptides |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101716283A (en) * | 2009-11-20 | 2010-06-02 | 合肥工业大学 | Method for constructing dendrobium officinale polysaccharide fingerprinting |
CN101724614A (en) * | 2010-01-12 | 2010-06-09 | 中南大学 | Acid beta-mannase, genes, engineering bacteria and structure thereof |
WO2010101129A1 (en) * | 2009-03-04 | 2010-09-10 | 財団法人野田産業科学研究所 | Transcription regulatory factors for mannanases or cellulases, and genes for the transcription regulatory factors |
US20110294166A1 (en) * | 2010-05-28 | 2011-12-01 | The Board Of Trustees Of The University Of Illinois | Thermostable enzymes for the hydrolysis of mannan-containing polysaccharides |
CN102676477A (en) * | 2011-08-19 | 2012-09-19 | 济南诺能生物工程有限公司 | Transformation of acidic beta-mannase gene and construction of engineering bacteria of acidic beta-mannase gene |
CN108611356A (en) * | 2016-12-10 | 2018-10-02 | 中国科学院大连化学物理研究所 | A kind of inscribe β -1,4- beta-mannase coding genes and its preparation and application |
CN109295131A (en) * | 2017-12-04 | 2019-02-01 | 合肥工业大学 | A kind of receptor positioning solid phase enzymolysis preparation of dendrobium nobile activated oligosaccharide |
-
2022
- 2022-04-12 CN CN202210378803.5A patent/CN114774392A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010101129A1 (en) * | 2009-03-04 | 2010-09-10 | 財団法人野田産業科学研究所 | Transcription regulatory factors for mannanases or cellulases, and genes for the transcription regulatory factors |
CN101716283A (en) * | 2009-11-20 | 2010-06-02 | 合肥工业大学 | Method for constructing dendrobium officinale polysaccharide fingerprinting |
CN101724614A (en) * | 2010-01-12 | 2010-06-09 | 中南大学 | Acid beta-mannase, genes, engineering bacteria and structure thereof |
US20110294166A1 (en) * | 2010-05-28 | 2011-12-01 | The Board Of Trustees Of The University Of Illinois | Thermostable enzymes for the hydrolysis of mannan-containing polysaccharides |
CN102676477A (en) * | 2011-08-19 | 2012-09-19 | 济南诺能生物工程有限公司 | Transformation of acidic beta-mannase gene and construction of engineering bacteria of acidic beta-mannase gene |
CN108611356A (en) * | 2016-12-10 | 2018-10-02 | 中国科学院大连化学物理研究所 | A kind of inscribe β -1,4- beta-mannase coding genes and its preparation and application |
CN109295131A (en) * | 2017-12-04 | 2019-02-01 | 合肥工业大学 | A kind of receptor positioning solid phase enzymolysis preparation of dendrobium nobile activated oligosaccharide |
Non-Patent Citations (3)
Title |
---|
WANG,L.S等: "mannan endo-1,4-beta-mannosidase A precursor [Aspergillus niger]" * |
张旭;李璐;曹雨婷;徐欣;李杰;: "黑曲霉MAN1基因在大肠杆菌中的表达及酶学性质分析" * |
陈冠;陶遵威;: "多糖指纹图谱的研究进展" * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024056643A1 (en) * | 2022-09-15 | 2024-03-21 | Novozymes A/S | Fungal signal peptides |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116286900B (en) | Acetic acid permease A gene RkAcpa and application thereof | |
CN115011616B (en) | Acetaldehyde dehydrogenase gene RKALDH and application thereof | |
CN113528480B (en) | Alpha-1, 2-fucosyltransferase mutant and construction method and application thereof | |
CN110950937B (en) | Modified Acermanium aikei Amuc _1100 protein and preparation method and application thereof | |
CN109957555B (en) | Glycosyl transferase mutant and application thereof in catalyzing biosynthesis of gastrodin | |
KR20200138420A (en) | Novel method of protein purification | |
CN114774392A (en) | Mannase and application thereof | |
CN110951814A (en) | Method for preparing prostaglandin E1 by using genetically engineered cyclooxygenase-1 and genetically engineered prostaglandin E synthetase-1 | |
CN111172089A (en) | Method for synthesizing trehalose by using recombinant trehalose synthase | |
CN110950941A (en) | Application of ssl2084 gene in synthesis of medium-long chain fatty acid | |
CN114231514B (en) | Recombinant algin lyase AlyL7 and application thereof | |
CN106834251B (en) | Phospholipase A2 and method for preparing 2-DHA-PS by using same | |
CN111808836B (en) | Heat-resistant mutant enzyme of pullulanase I and preparation method and application thereof | |
CN116286562A (en) | Genetically engineered bacterium and preparation method and application thereof | |
CN110257361B (en) | Algin lyase and gene and application thereof | |
CN109402090B (en) | Beta-1,3 endoglucanase with immune enhancing activity and derived from scapharca broughtonii and encoding polynucleotide thereof | |
CN115011622A (en) | Screening method and application of D-psicose 3-epimerase mutant | |
CN113088505B (en) | Application of polysaccharide lyase coding gene 04147 in preparation of recombinant peach gum polysaccharide hydrolase | |
CN114854778B (en) | Fucoidan gene Fcn1 and application thereof | |
CN116042561B (en) | S-adenosylmethionine synthetase mutant and application thereof | |
CN116144632B (en) | Tea tree neutral/alkaline invertase CsINV protein and preparation method and application thereof | |
CN115896138B (en) | Anaerobic sulfatase mature enzyme gene, anaerobic sulfatase mature enzyme, and preparation methods and application thereof | |
CN110066814B (en) | beta-D-glucosidase gene and encoding protein thereof | |
CN112410318B (en) | Novel phospholipase A2Gene, preparation method and application thereof | |
WO2024103822A1 (en) | Mature polypeptide for synthesizing oligosaccharides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220722 |